Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months
Clinical trial NCT00649883 · COMPLETED
Trial details
- NCT number
- NCT00649883
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-04-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.